Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

Multi-center determination of galectin-3 assay performance characteristics:

(2010) Robert H. Christenson et al.   CLINICAL BIOCHEMISTRY

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

(2010) Dirk J. A. Lok et al.   Clinical Research in Cardiology

Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure

(2010) Ravi V. Shah et al.   EUROPEAN JOURNAL OF HEART FAILURE

The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients

(2009) Yen-Hung Lin et al.   CLINICA CHIMICA ACTA

Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide

(2009) Hans Wedel et al.   EUROPEAN JOURNAL OF HEART FAILURE

Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover

(2009) Ramón Martos et al.   EUROPEAN JOURNAL OF HEART FAILURE

Galectin-3: a novel mediator of heart failure development and progression

(2009) Rudolf A. de Boer et al.   EUROPEAN JOURNAL OF HEART FAILURE

Galectin-3 regulates T-cell functions

(2009) Daniel K. Hsu et al.   IMMUNOLOGICAL REVIEWS

The regulation of inflammation by galectin-3

(2009) Neil C. Henderson et al.   IMMUNOLOGICAL REVIEWS

How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure?

(2009) Pompilio Faggiano et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction

(2009) Dirk J. van Veldhuisen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Heart Failure With Normal Left Ventricular Ejection Fraction: What is the Evidence?

(2009) Michael Kindermann et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Usefulness of N-Terminal Pro–Brain Natriuretic Peptide and Brain Natriuretic Peptide to Predict Cardiovascular Outcomes in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

(2008) Jasmine Grewal et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effect of Moderate or Intensive Disease Management Program on Outcome in Patients With Heart FailureCoordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH)

(2008) Tiny Jaarsma   ARCHIVES OF INTERNAL MEDICINE

The immunological potential of galectin-1 and -3

(2008) Amy Dhirapong et al.   AUTOIMMUNITY REVIEWS

14-3-3 protein regulates Ask1 signaling and protects against diabetic cardiomyopathy

(2008) Rajarajan A. Thandavarayan et al.   BIOCHEMICAL PHARMACOLOGY

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)

(2008) et al.   EUROPEAN HEART JOURNAL

Galectins: structure, function and therapeutic potential

(2008) Ri-Yao Yang et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Plasma Biomarkers of Myocardial Fibrosis and Remodeling in Terminal Heart Failure Patients Supported by Mechanical Circulatory Support Devices

(2008) Hendrik Milting et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)

(2008) Serge Masson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY